Home Companies Catalysts Deep Dives
AZD6234 AZD6234 PHASE2
Drug Profile
ModalitySmall molecule
RouteORAL
Therapy AreaCVRM
Formulations[]
Companies
AZN (ORIGINATOR)100%
Programs (1)
IndicationStageKey StudyRegional Status
Solid tumorsPHASE1—[]
Notes
SARA for obesity.
Data from Supabase · Updated 2026-03-24